Symbols / OSRH $0.55 -6.29% OSR Holdings, Inc.

Healthcare • Biotechnology • United States • NCM
OSRH Chart
About

OSR Holdings, Inc., a healthcare holding company, develops a portfolio of therapies and healthcare solutions in the United States, Switzerland, and South Korea. The company develops immunotherapy products, including VXM01, an immuno-oncology candidate for glioblastoma that is in phase 2 clinical trial, as well as preclinical stage products, such as VXM04 to treat mesothelin; VXM06 for the treatment of Wilms Tumor Protein (WT1); VXM08 for Carcinoembryonic antigen (CEA); and VXM10 for PD-L1. It is also developing design-augmented (DA) biologics comprising DRT-102, a clinical-stage asset for spinal fusion; and DRT-101, a pre-clinical stage asset for osteoarthritis. In addition, the company distributes neurovascular intervention medical device and systems. OSR Holdings, Inc. is based in Bellevue, Washington.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Biotechnology Market Cap 14.11M
Enterprise Value 70.31M Income -18.01M Sales 2.91M
Book/sh 3.46 Cash/sh 0.05 Dividend Yield —
Payout 0.00% Employees — IPO —
P/E — Forward P/E — PEG —
P/S 4.86 P/B 0.16 P/C —
EV/EBITDA -7.79 EV/Sales 24.20 Quick Ratio 0.12
Current Ratio 0.16 Debt/Eq 3.47 LT Debt/Eq —
EPS (ttm) -0.92 EPS next Y — EPS Growth —
Revenue Growth -58.30% Earnings 2026-03-31 16:00 ROA -13.21%
ROE -44.89% ROIC — Gross Margin 20.40%
Oper. Margin -16.75% Profit Margin 0.00% Shs Outstand 25.67M
Shs Float 10.13M Short Float 2.99% Short Ratio 0.87
Short Interest — 52W High 1.79 52W Low 0.38
Beta — Avg Volume 1.60M Volume 860.82K
Target Price $10.00 Recom Hold Prev Close $0.59
Price $0.55 Change -6.29%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$10.00
Mean price target
2. Current target
$0.55
Latest analyst target
3. DCF / Fair value
$3.73
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.55
Low
$10.00
High
$10.00
Mean
$10.00
News
RSS: Latest OSRH news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
Cost Of Revenue
—
2.53
0.00
Reconciled Cost Of Revenue
—
2.52
0.00
Gross Profit
—
0.92
0.00
Operating Expense
3.52
+92.52%
1.83
+194.65%
0.62
Research And Development
—
0.25
0.00
Selling General And Administration
3.52
+92.52%
1.83
+213.09%
0.58
Selling And Marketing Expense
—
0.01
0.00
General And Administrative Expense
3.52
+92.52%
1.83
+213.09%
0.58
Salaries And Wages
—
1.04
+159.03%
0.40
Other Gand A
3.52
+92.52%
1.83
+905.66%
0.18
Other Operating Expenses
—
0.02
+408.77%
0.00
Total Expenses
3.52
+92.52%
1.83
+194.65%
0.62
Operating Income
-3.52
-92.52%
-1.83
-194.65%
-0.62
Total Operating Income As Reported
-3.52
-92.52%
-1.83
-194.65%
-0.62
EBITDA
-2.07
-319.37%
0.94
-14.32%
1.10
Normalized EBITDA
-2.07
-319.37%
0.94
+259.85%
-0.59
Reconciled Depreciation
—
9.71
+41688.99%
0.02
EBIT
-2.07
-319.37%
0.94
-12.47%
1.08
Total Unusual Items
—
-0.41
-124.42%
1.69
Total Unusual Items Excluding Goodwill
—
-0.41
-124.42%
1.69
Special Income Charges
—
-0.31
-117.79%
1.75
Impairment Of Capital Assets
—
0.31
0.00
Write Off
—
0.00
-100.00%
0.08
Net Income
-2.41
-697.08%
0.40
-62.09%
1.06
Pretax Income
-2.12
-323.92%
0.94
-11.30%
1.06
Net Non Operating Interest Income Expense
1.41
-49.22%
2.78
+22721.61%
-0.01
Interest Expense Non Operating
0.04
0.00
-100.00%
0.01
Net Interest Income
1.41
-49.22%
2.78
+22721.61%
-0.01
Interest Expense
0.04
0.00
-100.00%
0.01
Interest Income Non Operating
1.45
-47.67%
2.78
+141761.86%
0.00
Interest Income
1.45
-47.67%
2.78
+141761.86%
0.00
Other Income Expense
—
-0.41
-123.96%
1.70
Other Non Operating Income Expenses
—
0.01
+26.84%
0.01
Gain On Sale Of Security
—
-0.10
-85.04%
-0.06
Tax Provision
0.30
-45.32%
0.54
0.00
Tax Rate For Calcs
0.00
+0.00%
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-2.41
-697.08%
0.40
-62.09%
1.06
Net Income From Continuing Operation Net Minority Interest
-2.41
-697.08%
0.40
-62.09%
1.06
Net Income From Continuing And Discontinued Operation
-2.41
-697.08%
0.40
-62.09%
1.06
Net Income Continuous Operations
-2.41
-697.08%
0.40
-62.09%
1.06
Minority Interests
—
0.00
0.00
Normalized Income
-2.41
-697.08%
0.40
+164.26%
-0.63
Net Income Common Stockholders
-2.41
-697.08%
0.40
-62.09%
1.06
Diluted EPS
-0.13
-166.75%
0.19
-62.09%
0.49
Basic EPS
-0.13
-166.75%
0.19
-62.09%
0.49
Basic Average Shares
19.28
+794.52%
2.15
+0.00%
2.15
Diluted Average Shares
19.28
+794.52%
2.15
+0.00%
2.15
Diluted NI Availto Com Stockholders
-2.41
-697.08%
0.40
-62.09%
1.06
Amortization
—
9.55
0.00
Amortization Of Intangibles Income Statement
—
9.55
0.00
Depreciation Amortization Depletion Income Statement
—
9.70
+41612.79%
0.02
Depreciation And Amortization In Income Statement
—
9.70
+41612.79%
0.02
Depreciation Income Statement
—
0.14
+520.96%
0.02
Gain On Sale Of PPE
—
0.00
-99.94%
1.83
Insurance And Claims
—
0.02
+1830.75%
0.00
Other Taxes
—
0.02
+142.36%
0.01
Provision For Doubtful Accounts
—
0.04
0.00
Rent And Landing Fees
—
0.02
+6884.61%
0.00
Rent Expense Supplemental
—
0.02
+6884.61%
0.00
Line Item Trend 2024-12-31 2023-12-31 2022-12-31
Total Assets
2.30
-93.71%
36.63
-69.67%
120.76
Current Assets
0.46
+1912.63%
0.02
-99.49%
4.42
Cash Cash Equivalents And Short Term Investments
0.07
+328.92%
0.02
-99.45%
2.82
Cash And Cash Equivalents
0.07
+328.92%
0.02
-99.45%
2.82
Other Short Term Investments
—
0.00
0.00
Receivables
0.30
0.00
-100.00%
0.51
Accounts Receivable
—
1,475.40
+396090.31%
0.37
Gross Accounts Receivable
—
1,520.89
+408306.43%
0.37
Allowance For Doubtful Accounts Receivable
—
-45.49
0.00
Other Receivables
—
68.14
+55723.38%
0.12
Taxes Receivable
—
6.71
+58184.23%
0.01
Loans Receivable
—
0.00
—
Inventory
—
1,802.61
+166983.36%
1.08
Finished Goods
—
1,802.61
+166983.36%
1.08
Prepaid Assets
—
160.28
+981990.92%
0.02
Other Current Assets
0.09
+1138.39%
0.01
—
Total Non Current Assets
1.85
-94.95%
36.61
-68.54%
116.34
Net PPE
—
235.44
+63257.85%
0.37
Gross PPE
—
897.98
+161397.68%
0.56
Accumulated Depreciation
—
-662.54
-359131.86%
-0.18
Properties
—
0.00
0.00
Buildings And Improvements
—
328.81
+112418.45%
0.29
Machinery Furniture Equipment
—
500.90
+237322.59%
0.21
Construction In Progress
—
34.92
+65993.76%
0.05
Other Properties
—
33.35
—
Goodwill And Other Intangible Assets
—
278,365.58
+240452.42%
115.72
Goodwill
—
47,516.59
+391597.68%
12.13
Other Intangible Assets
—
230,848.99
+222752.23%
103.59
Investments And Advances
—
7.95
+150210.40%
0.01
Non Current Deferred Assets
—
107.39
+421973.37%
0.03
Non Current Deferred Taxes Assets
—
107.39
+421973.37%
0.03
Other Non Current Assets
1.85
-94.95%
36.61
+3603190936.98%
0.00
Total Liabilities Net Minority Interest
8.79
+113.93%
4.11
-81.03%
21.66
Current Liabilities
6.72
+229.63%
2.04
-65.22%
5.86
Payables And Accrued Expenses
4.16
+103.89%
2.04
-55.39%
4.57
Payables
4.16
+103.89%
2.04
-52.15%
4.26
Accounts Payable
2.88
+166.42%
1.08
-74.58%
4.26
Current Accrued Expenses
—
558.55
+180901.58%
0.31
Employee Benefits
—
2.44
0.00
Pensionand Other Post Retirement Benefit Plans Current
—
27.80
+194229.94%
0.01
Total Tax Payable
1.20
+35.87%
0.88
+20598.89%
0.00
Income Tax Payable
0.36
-31.69%
0.52
+12175.43%
0.00
Current Debt And Capital Lease Obligation
2.56
-99.58%
605.83
+50936.88%
1.19
Current Debt
2.56
-99.49%
500.00
+43854.34%
1.14
Other Current Borrowings
0.80
-99.84%
500.00
+54648.93%
0.91
Current Capital Lease Obligation
—
105.83
+213706.60%
0.05
Other Current Liabilities
—
78.34
+86304.80%
0.09
Total Non Current Liabilities Net Minority Interest
2.07
+0.00%
2.07
-86.90%
15.80
Long Term Debt And Capital Lease Obligation
—
561.66
+150200.93%
0.37
Long Term Debt
—
460.00
+362986.61%
0.13
Long Term Capital Lease Obligation
—
101.66
+41057.39%
0.25
Non Current Pension And Other Postretirement Benefit Plans
—
2.44
0.00
Non Current Deferred Liabilities
2.07
+0.00%
2.07
-86.58%
15.42
Non Current Deferred Taxes Liabilities
—
43,328.01
+280795.29%
15.42
Stockholders Equity
-6.49
-119.94%
32.52
-67.18%
99.10
Common Stock Equity
-6.49
-119.94%
32.52
-67.18%
99.10
Capital Stock
1.85
-94.93%
36.43
+692.70%
4.60
Common Stock
1.85
-94.93%
36.43
+692.70%
4.60
Preferred Stock
0.00
0.00
—
Share Issued
19.28
+0.00%
19.28
+0.00%
19.28
Ordinary Shares Number
19.28
+0.00%
19.28
+0.00%
19.28
Additional Paid In Capital
0.00
0.00
-100.00%
94.45
Retained Earnings
-8.33
-113.30%
-3.91
-7456.36%
0.05
Gains Losses Not Affecting Retained Earnings
—
168.94
0.00
Minority Interest
—
0.00
0.00
Other Equity Adjustments
—
168.94
—
Total Equity Gross Minority Interest
-6.49
-119.94%
32.52
-67.18%
99.10
Total Capitalization
-6.49
-119.94%
32.52
-67.23%
99.23
Working Capital
-6.26
-210.74%
-2.02
-39.67%
-1.44
Invested Capital
-3.92
-112.06%
32.52
-67.60%
100.36
Total Debt
2.56
-99.78%
1,167.49
+74703.86%
1.56
Net Debt
2.50
-99.05%
263.46
—
Capital Lease Obligations
—
207.49
+69879.90%
0.30
Net Tangible Assets
-6.49
-119.94%
32.52
+295.65%
-16.62
Tangible Book Value
-6.49
-119.94%
32.52
+295.65%
-16.62
Available For Sale Securities
—
7.95
+150210.40%
0.01
Current Notes Payable
1.76
0.00
—
Duefrom Related Parties Current
0.30
0.00
—
Dueto Related Parties Current
0.07
+0.00%
0.07
—
Investmentin Financial Assets
—
7.95
+150210.40%
0.01
Line Of Credit
—
0.00
-100.00%
0.22
Non Current Note Receivables
—
440.42
+201462.88%
0.22
Line Item Trend 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-2.19
-167.22%
-0.82
-58.58%
-0.52
Cash Flow From Continuing Operating Activities
-2.19
-167.22%
-0.82
-58.58%
-0.52
Net Income From Continuing Operations
-2.41
-697.08%
0.40
-62.08%
1.06
Depreciation Amortization Depletion
—
9.71
+41688.99%
0.02
Depreciation
—
0.08
+231.55%
0.02
Amortization Cash Flow
—
9.64
0.00
Depreciation And Amortization
—
9.71
+41688.99%
0.02
Amortization Of Intangibles
—
9.64
0.00
Other Non Cash Items
-1.45
+47.75%
-2.78
-23375.35%
0.01
Pension And Employee Benefit Expense
—
0.07
0.00
Provisionand Write Offof Assets
—
0.03
0.00
Asset Impairment Charge
—
0.31
+303.42%
0.08
Deferred Tax
—
0.00
+101.75%
-0.15
Deferred Income Tax
—
0.00
+101.75%
-0.15
Operating Gains Losses
—
0.15
+108.02%
-1.82
Net Foreign Currency Exchange Gain Loss
—
0.08
+782.26%
0.01
Gain Loss On Sale Of PPE
—
-0.00
0.00
Change In Working Capital
1.67
+7.76%
1.55
+1057.32%
0.13
Change In Receivables
—
-0.75
-18155.92%
0.00
Change In Inventory
—
-0.33
0.00
Change In Prepaid Assets
-0.08
-1038.39%
-0.01
—
Change In Payables And Accrued Expense
1.76
+12.52%
1.56
+1528.10%
0.10
Change In Payable
1.76
+12.52%
1.56
+1528.10%
0.10
Change In Account Payable
1.80
+73.87%
1.04
—
Change In Other Current Assets
—
-0.05
-852.99%
-0.01
Change In Other Current Liabilities
—
-0.03
-167.95%
0.04
Investing Cash Flow
35.91
+206.14%
-33.83
-1876.81%
-1.71
Cash Flow From Continuing Investing Activities
35.91
+206.14%
-33.83
-1876.81%
-1.71
Net PPE Purchase And Sale
—
-0.01
+92.90%
-0.08
Purchase Of PPE
—
-0.01
+88.53%
-0.08
Sale Of PPE
—
0.00
0.00
Capital Expenditure
—
-0.02
+78.92%
-0.08
Net Investment Purchase And Sale
35.75
-0.18%
35.82
+1148.71%
-3.42
Purchase Of Investment
-0.48
-166.67%
-0.18
+94.73%
-3.42
Sale Of Investment
36.23
+0.66%
36.00
—
Net Business Purchase And Sale
—
0.00
-100.00%
1.78
Net Intangibles Purchase And Sale
—
-0.01
0.00
Purchase Of Intangibles
—
-0.01
0.00
Net Other Investing Changes
-0.30
+99.57%
-70.21
—
Financing Cash Flow
-33.67
-197.48%
34.54
+632.46%
4.72
Cash Flow From Continuing Financing Activities
-33.67
-197.48%
34.54
+632.46%
4.72
Net Issuance Payments Of Debt
2.56
+313.58%
-1.20
-212.60%
1.07
Issuance Of Debt
2.60
0.00
-100.00%
1.25
Repayment Of Debt
-0.04
+96.67%
-1.20
-563.85%
-0.18
Long Term Debt Issuance
—
1.12
-10.16%
1.25
Long Term Debt Payments
—
-0.49
-168.74%
-0.18
Net Long Term Debt Issuance
—
0.63
-40.50%
1.07
Short Term Debt Issuance
2.60
0.00
0.00
Short Term Debt Payments
-0.04
+96.67%
-1.20
0.00
Net Short Term Debt Issuance
2.56
+313.58%
-1.20
0.00
Net Common Stock Issuance
-36.23
-197.58%
37.13
+917.34%
3.65
Common Stock Payments
-36.23
-0.66%
-36.00
—
Repurchase Of Capital Stock
-36.23
-0.66%
-36.00
—
Net Other Financing Charges
—
-1.39
—
Changes In Cash
0.05
+146.49%
-0.11
-104.38%
2.49
Effect Of Exchange Rate Changes
—
-0.03
-49.37%
-0.02
Beginning Cash Position
0.02
-87.62%
0.12
-64.35%
0.35
End Cash Position
0.07
+328.92%
0.02
-99.45%
2.82
Free Cash Flow
-2.19
-167.22%
-0.82
-37.91%
-0.59
Income Tax Paid Supplemental Data
0.46
0.00
—
Change In Income Tax Payable
-0.05
-108.59%
0.52
—
Change In Tax Payable
-0.05
-108.59%
0.52
—
Common Stock Issuance
0.00
-100.00%
73.13
+1903.56%
3.65
Interest Paid CFO
—
-0.05
-332.81%
-0.01
Interest Received CFI
0.46
-18.92%
0.56
—
Interest Received CFO
—
0.03
+5275.61%
0.00
Issuance Of Capital Stock
0.00
-100.00%
73.13
+1903.56%
3.65
Sale Of Business
—
0.00
-100.00%
1.78
Taxes Refund Paid
—
-0.01
-109.59%
0.15
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category